RBC Capital analyst Deane Dray keeps an Outperform rating and $182 price target on Ametek after the firm hosted investor meetings with its CEO yesterday. The takeaways from the meeting suggest that underlying demand remains solid and the M&A funnel is active with attractive bolt-on opportunities, the analyst tells investors in a research note. The firm added that de-stocking in medtech and semis, discussed in Q2, continues, driven by supply chain normalization rather than end market slowing.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AME: